Cetnine PFS 0.25mg Injection
Marketer
Eris Lifesciences Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetnine PFS 0.25mg Injection
GnRH antagonist Cetnine PFS 0.25mg Injection treats female infertility by suppressing egg release and preventing premature ovulation. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Home administration, if instructed, should be guided by your doctor or nurse. Dosage frequency varies depending on the treatment plan, determined by your physician to optimize results. Continue treatment as prescribed. Common side effects include injection site reactions (erythema, pruritus, inflammation), nausea, and emesis. Rotate injection sites (abdomen) daily to minimize irritation. Seek immediate medical attention for dizziness, syncope, abdominal pain, or severe vomiting. Prior to commencing therapy, disclose any history of hepatic or renal impairment, and inform your doctor of all concurrent medications, as interactions may affect efficacy or alter the drug's action. Breastfeeding should also be reported.
Uses of Cetnine PFS 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetnine PFS 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cetnine PFS 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetnine PFS 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cetnine PFS 0.25mg Injection works:
Infertility treatments in women occasionally encounter premature egg release, yielding ova unsuitable for fertilization. Cetnine PFS 0.25mg Injection inhibits a key hormone, thereby preventing this premature ovarian expulsion of eggs.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Cetnine PFS 0.25mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetnine PFS 0.25mg Injection to pregnant individuals carries a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects indicates considerable potential harm to the fetus.
Breast feedingUNSAFE
Administration of Cetnine PFS 0.25mg Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingSAFE
Administration of Cetnine PFS 0.25mg Injection typically does not impair driving ability.
KidneyCAUTION
Patients with kidney impairment should receive Cetnine PFS 0.25mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Cetnine PFS 0.25mg Injection is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Administering Cetnine PFS 0.25mg Injection requires careful consideration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cetnine PFS 0.25mg Injection :
Omit a dose of Cetnine PFS 0.25mg Injection? Seek your physician's advice.
Facts to Know About Cetnine PFS 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | GnRH receptor blockers |
3,018 People bought this recently